Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
Since pulse oximetry technology was developed in nondiverse populations, racial bias may influence the accuracy of pulse oximeter readings.
An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.
Although asthma and autoimmune disease are thought to have mutually exclusive pathogeneses, they both result from a dysregulated immune system.
The gains in the global fight against tuberculosis have been threatened as a result of the COVID-19 pandemic, including a diversion of resources that have led to disruptions in ongoing research and control programs.
MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.
Whatever strategy you employ to encourage vaccinations, it is important to be respectful and empathize with your patient’s concerns and perspectives.
Fear of the COVID-19 pandemic has caused patients to cancel or delay necessary cancer screenings, diagnostic tests, wellness exams, elective surgeries, and immunizations; the repercussions of this may be immediate, or not seen for months to years.
Polyethylene glycol (PEG) found in mRNA-based COVID vaccines, Pfizer and Moderna, have excluded patients due to risk of allergic reactions, including anaphylaxis; the recent approval of Janssen’s COVID-19 vaccine, which contains polysorbate, provides an alternative for this population.
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.